Production (Stage)
GRI Bio, Inc.
GRI
$1.36
$0.064.62%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -3.05M | -1.95M | -2.12M | -2.25M | -1.89M |
Total Depreciation and Amortization | 12.00K | -103.00K | 1.00K | -13.00K | 15.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 220.00K | 203.00K | 47.00K | -91.00K | 35.00K |
Change in Net Operating Assets | 1.08M | -101.00K | -194.00K | 213.00K | -366.00K |
Cash from Operations | -1.74M | -2.00M | -2.27M | -2.14M | -2.20M |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | 2.38M | 1.03M | 4.96M | 5.50M |
Repurchase of Common Stock | -1.00K | 0.00 | -1.00K | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -10.00K | -96.00K | -366.00K | -557.00K | -1.01M |
Cash from Financing | -11.00K | 2.28M | 661.00K | 4.40M | 4.49M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -1.75M | 282.00K | -1.61M | 2.26M | 2.28M |